PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
39.41%
Net income growth under 50% of CSIQ's 84.91%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
52.52%
D&A growth well above CSIQ's 7.35%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
134.72%
Deferred tax of 134.72% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
25.91%
SBC growth of 25.91% while CSIQ is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
92.45%
Well above CSIQ's 22.59% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-4.51%
AR is negative yoy while CSIQ is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
35.12%
Inventory growth of 35.12% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
105.06%
AP growth of 105.06% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
947.03%
Growth of 947.03% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-106.77%
Negative yoy while CSIQ is 73.66%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
85.81%
Operating cash flow growth below 50% of CSIQ's 513.84%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
-20.07%
Negative yoy CapEx while CSIQ is 6.85%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-88.72%
We reduce yoy sales while CSIQ is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
-1996.72%
Both yoy lines negative, with CSIQ at -61.75%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-156.15%
We reduce yoy invests while CSIQ stands at 4.71%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
130.19%
Debt repayment growth of 130.19% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
75.88%
Buyback growth of 75.88% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.